The Guardian Connect App CSS7200 iOS - Product Usage: intended for use by patients with a compati...

FDA Device Recall #Z-2980-2020 — Class II — July 15, 2020

Recall Summary

Recall Number Z-2980-2020
Classification Class II — Moderate risk
Date Initiated July 15, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Inc.
Location Northridge, CA
Product Type Devices
Quantity 3,588 users

Product Description

The Guardian Connect App CSS7200 iOS - Product Usage: intended for use by patients with a compatible consumer mobile device.

Reason for Recall

As a result of the release of new software version to CareLink Personal website, the IOS app for the Continuous Monitoring Glucose system stopped automatically uploading data to the website.

Distribution Pattern

International distribution including in the countries of EMEA - Austria, Belgium, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kuwait, Latvia, Luxembourg, The Netherlands, Poland, Portugal, Romania, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, United Arab Emirates, and United Kingdom. Latin America- Chile, Colombia and Mexico Asia Pacific (APAC) - Australia, India, Japan, The Republic of Korea, Malaysia, New Zealand, Russia Federation, Singapore, Thailand, and Vietnam. Asia - Hong Kong North America - Canada

Lot / Code Information

Product Number - CSS7200 UDI (GTIN.UPN) - 00763000255404

Other Recalls from Medtronic Inc.

Recall # Classification Product Date
Z-3152-2024 Class II 2090 Programmers with serial number prefixes PK... Jul 11, 2024
Z-2197-2024 Class II EVERA MRI S VR SureScan, Model Number DVMC3D4, ... Apr 16, 2024
Z-2206-2024 Class II COBALT DR MRI SureScan, Model Number DDPB3D1, I... Apr 16, 2024
Z-2190-2024 Class II COBALT HF QUAD CRT-D MRI SureScan, Model Number... Apr 16, 2024
Z-2210-2024 Class II COBALT XT VR MRI SureScan, Model Number DVPA2D1... Apr 16, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.